Evidence map›Paper›PMID 36056299›Full record

ArticleBMC infectious diseases2022

Self-testing for SARS-CoV-2 in São Paulo, Brazil: results of a population-based values and attitudes survey.

Guillermo Z Martínez-Pérez, Sonjelle Shilton, Maíra Saruê, Hilton Cesario, Abhik Banerji, Deepshikha Batheja, João Paulo Cunha, Rachel Baptista, Janine Schirmer, Eleva Ivanova Reipold and 1 more

Abstract read
In one paragraph

Article in BMC infectious diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Observational
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. COVID-19 self-testing in Brazil and the imminent risk of underreporting cases.Revista da Sociedade Brasileira de Medicina Tropical · 2023
    Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Guillermo Z Martínez-PérezFIND, The Global Alliance for Diagnostics, Geneva, Switzerland.
Sonjelle ShiltonFIND, The Global Alliance for Diagnostics, Geneva, Switzerland. sonjelle.shilton@finddx.org.
Maíra SaruêInstituto Locomotiva, São Paulo, Brazil.
Hilton CesarioInstituto Locomotiva, São Paulo, Brazil.
Abhik BanerjiCenter for Disease Dynamics, Economics & Policy (CDDEP), New Delhi, India.
Deepshikha BathejaCenter for Disease Dynamics, Economics & Policy (CDDEP), New Delhi, India.
João Paulo CunhaInstituto Locomotiva, São Paulo, Brazil.
Rachel BaptistaInstituto Locomotiva, São Paulo, Brazil.
Janine SchirmerDepartment of Nursing, Federal University of São Paulo, São Paulo, Brazil.
Eleva Ivanova ReipoldFIND, The Global Alliance for Diagnostics, Geneva, Switzerland.
Alvaro Machado DiasClinical Neuroscience Lab, Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBrazil is among the countries in South America where the COVID-19 pandemic has hit the general population hardest. Self-testing for SARS-CoV-2 infection is one of the community-based strategies that could help asymptomatic individuals at-risk of COVID-19, as well as those living in areas that are difficult for health personnel to reach, to know their infectious status and contribute to impeding further transmission of the virus.

methodsA population-based survey was conducted in November 2021, to assess the acceptability of rapid SARS-CoV-2 antigen self-testing among the population of São Paulo. Survey respondents were approached at more than 400 different street-points that were randomly selected using a five-stage randomization process. A 35-item structured questionnaire was used. Dependent variables for our analyses were the likelihood to use and willingness to pay for self-testing, and the likelihood of taking preventive measures to prevent onward transmission of SARS-CoV-2 following a reactive self-test result. Bivariate and multivariate regression analyses were performed.

resultsOverall, 417 respondents (44.12% female) participated; 19.66% had previously had COVID-19 disease. A minority (9.59%) felt at high-risk of COVID-19. The majority of both females and males (73.91% and 60.09%, respectively) were in favor of the idea of SARS-CoV-2 self-testing. Overall, if self-tests were available, almost half of the sample would be very likely (n = 54, 12.95%) or likely (n = 151, 36.21%) to use one if they felt they needed to. Upon receiving a positive self-test result, the majority of respondents would communicate it (88.49%), request facility-based post-test counseling (98.32%), self-isolate (97.60%), and warn their close contacts (96.64%).

conclusionRapid SARS-CoV-2 antigen self-testing could be an acceptable screening tool in São Paulo. The population would be empowered by having access to a technology that would allow them to test, even if asymptomatic, when traveling, or going to work or school. If there is a surge in the incidence of cases, self-testing could be a good approach for mass case detection by Brazil's already overstretched Unified Health System.

Indexed as

COVID-19SARS-CoV-2AttitudeBrazilFemaleHumansMalePandemicsSelf-TestingSurveys and QuestionnairesBrazilCOVID-19Home diagnosticsSARS-CoV-2 testingSelf-testingSurvey

Identifiers

PMID36056299
PMCPMC9438865

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.